Clinical Trials Directory

Trials / Unknown

UnknownNCT00313105

Smoking Cessation With Smokeless Tobacco, Nicotine Tablets and Nicotine Patches

Smoking Cessation by Nurses With Smokeless Tobacco Buccal Tablets, Nicotine Buccal Tablets, Nicotine Patches With Repeated Therapy Every 6 Months for 2 Years

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
600 (estimated)
Sponsor
University Hospital, Gentofte, Copenhagen · Academic / Other
Sex
All
Age
25 Years – 70 Years
Healthy volunteers
Accepted

Summary

To test if smokeless tobacco is more effective than nicotine buccal tablets in smoking cessation compared with a control group with low dose nicotine patches. Also retreatment will be tested with smokeless tobacco every 6 months in failures for 1½ year. Adherence to the program will be enhanced by assessment of cholesterol, blood pressure, lung function and body weight every 6 months for 2 years.

Detailed description

This is an open randomized controlled trial with 3 groups testing smokeless tobacco in smoking cessation: 200 smokers will get smokeless tobacco for 3 months, 200 will get nicotine buccal tablets for 3 months and 200 will get 7-mg nicotine patches for 3 months (control arm). After ½, 1 and 1½ a year failures will get smokeless tobacco in the first 2 groups, while only 7 mg nicotine patches in control group until 1½ year where failures in this group also will get smokeless tobacco. Every ½ year cholesterol, blood pressure, lung function and BMI will be assessed and used to enhance adherence of the participants in this trial.

Conditions

Interventions

TypeNameDescription
DRUGSmokeless tobacco (Oliver Twist pellets)individual visits with counseling
BEHAVIORALsmoking cessation counselingindividual visits

Timeline

Start date
2006-04-01
Primary completion
2010-04-01
Completion
2010-08-01
First posted
2006-04-11
Last updated
2009-09-15

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00313105. Inclusion in this directory is not an endorsement.